Cocaine is to blame
AstraZeneca makes analyst cry
Chasing Value: Analysts’ Bad Advice on Arena
Looking to Play Defense? Buy Pfizer
Allergan Second Quarter Earnings Preview
Walgreen and CVS Caremark in Benefits Row
Health Insurers Get Brief Relief on Proposed Tax
Filed under: Pfizer (PFE), Boston Scientific (BSX)
Insurance companies just bought themselves a year. Claiming that a proposed tax on health insurance would force them to charge higher premiums, carriers were able to convince senators to defer this particular measure for a year.
This comes as a benefit to...
Madoff: Chillin’ with mobsters and spies
Filed under: Scandals, Headline news
Bernie Madoff is getting used to his new neighbors. Gone are the days of Montauk and Manhattan, and he isn't sharing his space with topless dancers.
Some big names setting new highs today: STAR, GG, PIR, EBAY
Filed under: Major movement, Cisco Systems (CSCO), eBay (EBAY), Market matters, Halliburton (HAL), Goldman Sachs Group (GS), Goldcorp Inc (GG), Commodities, S and P 500, DJIA, NASDAQ
Some big names setting new highs: INTC, STX, SGP
Filed under: Major movement, Earnings reports, Good news, Apple Inc (AAPL), Cisco Systems (CSCO), Intel (INTC), Market matters, Walt Disney (DIS), Target Corp. (TGT), S and P 500, DJIA, NASDAQ
Warner Chilcott strikes a healthy deal for P&G unit
Filed under: Deals, Procter and Gamble (PG)
The dealmaking continues apace in the drug sector. Today, Warner Chilcott plc (NASDAQ: WCRX) agreed to shell out $3.1 billion for the global pharma business of Procter & Gamble (NYSE: PG). The deal...
Wyeth (WYE) shareholders approve sell to Pfizer (PFE)
Filed under: Pfizer (PFE)
The mega pharmaceutical merger between Wyeth (NYSE: WYE) and Pfizer (NYSE: PFE) is one step closer to becoming official today after overwhelming approval by Wyeth shareholders.The shareholder vote to sell Wyeth to Pfizer was...
Follow seriouslyfinace on Twitter!
